Hoshi Corporation Successfully Develops 3 Types of Made-in-Japan Health Food Supplements with Satisfactory Clinical Evidence

Food and Healthcare Press Releases Tuesday August 1, 2017 13:00
TOKYO--1 Aug--Kyodo JBN-AsiaNet/InfoQuest
  • Accepting Orders from July 24, 2017, amid Increasing Awareness of Health Promotion -

Hoshi Corporation, a cosmetic, quasi-drug and health food supplement manufacturer headquartered in Japan, has developed three types of health food supplements that are safe and secure. Based on our production philosophy of safe and high-quality product creation, we have developed over 20,000 products distributed all over the world.

Against the background of increasing awareness for health, beauty and longevity, we began accepting orders of safe and secure food supplements from July 24, 2017. Our made-in-Japan high-quality food supplements are available for import or for sale as your original products.

(Photo: http://prw.kyodonews.jp/img/201707284188-O1-UKtK77J8 )
Website: http://hoshicorp.jp/business/cosmeticsupplement/
Devices available for access: PCs, mobile phones
Product Information
1. Pueraria Mirifica Extract-containing Food Supplement (with Collagen)
We have completed clinical tests on this "Pueraria Mirifica"-containing supplement and obtained trial results of easing symptoms for women in menopausal disorder.
RESEARCH PAPER
(1) Efficacy on Breast Skin Tension of the Supplement Containing Pueraria Mirifica in Healthy Japanese Females: A Randomized, Double-blind, Placebo-controlled Study
  • Masatomo NAJIMA (JACTA (Japan Clinical Trial Association))
  • Akinobu MIYATA (Nihonbashi M's Clinic)
  • Hiroyuki SASAGAWA (Hoshi Corporation)
(2) Efficacy on Menopausal Discomfort of the Supplement Containing Pueraria Mirifica in Healthy Japanese Females: A Randomized, Double-blind, Placebo-controlled Study
  • Masatomo NAJIMA (JACTA (Japan Clinical Trial Association))
  • Mitsuhiko MUNEKATA (OZ Clinic)
  • Hiroyuki SASAGAWA (Hoshi Corporation)
2. RELAX & SLEEP - The good quality of sleep -

This health food supplement is a combination of "Theanine" which is widely known as functional food (*) and "PC-DHA" that is a kind of unsaturated fat of DHA (docosahexaenoic acid). It is actually reported that one in every five Japanese has some sleep disorders and troubles. (Reference from Annual Health, Labor and Welfare Report 2015)

Against the background of sleep disorder known as a modern disease, we have developed a food supplement to ensure sound sleep.
(*) Functional food is strictly examined as to its effects on health and registered with the Consumer Agency of Japan. It is a Japanese original system based on scientific grounds.
3. Placenta Drink, Placenta Jelly

It can be said that international scrutiny towards animal-derived ingredients becomes increasingly severe. MP (Marine Placenta) is extracted and purified from ovary membranes of domestic natural Hokkaido salmon. We have developed MP-containing jelly and drink. Fish-derived ingredients can give natural images to consumers. They feature our original formulation with 100% Japanese ingredients, non-caffeine and low calorie.

About Hoshi Corporation
Headquarters: 31-2, Kanda Higashi Matsushita-Cho, Chiyoda-Ku, Tokyo, 101-0042, JAPAN
Founded:   April 30, 1975
Capital:   80,000,000 yen
CEO:       Tsuneo Hoshino
President: Katsuo Kawashima
Major business areas:
  • Sales of cosmetic, pharmaceutical and health foods
  • Planning and sales of containers and packaging materials
  • Planning and contract manufacturing of cosmetic, pharmaceutical and health foods
SOURCE: Hoshi Corporation
AsiaNet 69505

Latest Press Release

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

NovoEight(R) Maintains Potency When Stored at 40?C Offering People With Haemophilia A Increased Flexibility in Their Daily Lives

A new long term stability study has shown that haemophilia A treatment NovoEight(R) (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow,...

Related Topics